bf/NYSE:ABBV_icon.jpeg

NYSE:ABBV

AbbVie Inc.

  • Stock

USD

Last Close

209.17

25/03 15:30

Market Cap

296.91B

Beta: 0.55

Volume Today

1.78M

Avg: 6.07M

PE Ratio

46.58

PFCF: 12.27

Dividend Yield

3.48%

Payout:159.95%

  • name

    AbbVie Inc.
  • homepage url

    www.abbvie.com
  • country

    USUnited States
  • crunchbase url

    abbvie
  • employee count

    50,000
  • sector

    Healthcare
  • industry

    Drug Manufacturers - General
  • revenue

    54.32B
  • monthly webtraffic

    1.18M
  • monthly webtraffic growth

    50.67%
  • raised capital

    15B

Description

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients;...Show More

Earnings

Earnings per Share (Estimate*)

12342017-04-272019-04-252021-04-302023-04-272024-10-25

Revenue (Estimate*)

5B10B15B2017-04-272019-04-252021-04-302023-04-272024-10-25

*Estimate based on analyst consensus